Frontage Holdings
Frontage Holdings Corporation is a contract research organization that offers a comprehensive range of research, analytical, and development services to pharmaceutical, biotechnology, and agrochemical companies. Established in 2018 and headquartered in Exton, Pennsylvania, the company supports drug discovery and development through services such as drug metabolism, pharmacokinetics, safety and toxicology, and bioanalytical testing. Additionally, Frontage provides product development and bioequivalence services that assist generic and consumer health pharmaceutical firms in their regulatory submissions. With operations in North America, including the United States and Canada, as well as in the People's Republic of China and other global markets, Frontage Holdings aims to facilitate the advancement of biopharmaceutical research and development from early stages to late-stage clinical trials. The company is a subsidiary of Hong Kong Tigermed Co., Limited.
Ocean Ridge Biosciences is a life science company in the research tools sector of biotechnology that provides accurate, affordable, and information-rich genomic services to the Health Care and Life Science industries. Headquartered in Deerfield Beach, they are centrally located within the South Florida metropolis within easy reach of major research universities, institutes, and hospitals. Demand for high-quality genomic services is steadily increasing for both research and clinical applications.
Acme Bioscience is a biological research and development organization based in Palo Alto, California, specializing in a range of chemistry services tailored for biopharmaceutical companies. The company offers discovery chemistry, medicinal chemistry, and process chemistry research and development, along with chemical manufacturing services. Acme Bioscience has significant expertise in antiviral and antibacterial research, as well as in the synthesis of nucleotides, nucleosides, triphosphates, pro-drugs, heterocycles, and boron-containing compounds. In addition to these services, the company provides custom synthesis, biological tests, and analytical services, including X-ray analysis. Acme collaborates closely with clients to address complex medicinal challenges and facilitate the development of new chemical entities.
Concord Biosciences provides a range of non-clinical discovery support and integrated research and development services aimed at facilitating drug candidate development from lead identification to regulatory submission. The company's capabilities encompass early pharmacokinetic and metabolism screening, pilot toxicology evaluations, and IND/NDA-enabling toxicology and DMPK development for both small molecules and biologics. Additionally, Concord offers synthetic, medicinal, and process chemistry services, along with radiochemistry and cGMP API manufacturing, supporting both small-scale clinical batches and commercial API production. By employing experienced scientists, Concord aims to accelerate the drug development process, enabling faster transition from compound lead selection to regulatory filing. Operating from a single research site in Concord, Ohio, the company is equipped to handle projects of various sizes and complexities, delivering integrated services tailored to meet the needs of its clients in the pharmaceutical and agricultural chemicals sectors.
BDM Consulting is an independent CRO specializing in biostatistics. SAS programming, and data management. BDM is composed of a group of more than 35 critical talents/experts, who excel and stand out among their peers in the industry. Its clients and partners include pharmaceutical, biotechnology, medical device companies and CROs. Striving to high quality, BDM focuses on reducing the time, cost and risk of bringing new pharmaceutical products to market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.